Fleebs-Logo
Details werden geladen...

Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight | The Manila Times

A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.

Ähnliche Seiten

https://www.finanznachrichten.de/nachrichten-2026-05/68611208-gene-solutions-sgp-pte-ltd-fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test-008.htm

GENE SOLUTIONS SGP PTE. LTD.: FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test

https://www.finanznachrichten.de/nachrichten-2026-05/68611208-gene-solutions-sgp-pte-ltd-fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test-008.htm
https://www.manilatimes.net/2026/05/28/tmt-newswire/pr-newswire/fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test/2353202

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test | The Manila Times

https://www.manilatimes.net/2026/05/28/tmt-newswire/pr-newswire/fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test/2353202
https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/novartis-advances-rlt-innovation-and-reinforces-leadership-in-prostate-cancer-breast-cancer-and-hematology-with-new-data-at-asco-and-eha/2348825

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA | The Manila Times

https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/novartis-advances-rlt-innovation-and-reinforces-leadership-in-prostate-cancer-breast-cancer-and-hematology-with-new-data-at-asco-and-eha/2348825